BG505 SOSIP.GT1.1 gp140 vaccine

recombinant HIV-1 envelope gp140 vaccine BG505 SOSIP.GT1.1 · International AIDS Vaccine Initiative

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BG505 SOSIP.GT1.1 gp140 vaccine, covering 2024-06-11 to 2024-12-05. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Protein BG505 SOSIP.GT1.1 Gp140 Vaccine, Adjuvanted in Healthy, HIV-uninfected Adults [Phase 1]

See pricing